RTX business Raytheon will manufacture additional AIM-9X Sidewinder missiles under a $1.1 billion modification of a previously awarded contract. The modification exercises options of the previous ...
The Department of Defense said Monday the new flight science aircraft will help avert any rise in the test capability gap and enable future flight science testing of Block 4 capabilities in support of ...
General Dynamics Electric Boat (GDEB) has received a $1.85bn contract modification for the procurement of long lead time materials and to initiate preliminary construction activities for the US Navy ...
Jet-engine manufacturer Pratt & Whitney has been awarded an approximately $670 million contract modification from the U.S. Department of War for additional production of F135 engines for F-35 fighter ...
NEWPORT NEWS, Va., April 30, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that the Virginia-class shipbuilding team, which includes the company’s Newport News Shipbuilding (NNS) division, ...
"This new contract modification is the next step in our ongoing engagement with the U.S. government, with the shared goal to help ensure medical countermeasures, like CYFENDUS ® vaccine, are readily ...
Emergent BioSolutions Inc. announced a contract modification with the U.S. Department of Health and Human Services to provide additional doses of its smallpox treatment, CNJ-016® (Vaccinia Immune ...
Emergent BioSolutions receives a $62.4 million contract modification to supply Botulism Antitoxin for U.S. public health protection. Emergent BioSolutions Inc. announced the award of a $62.4 million ...
The U.S. Navy last week awarded the Electric Boats subsidiary of Reston-based Fortune 100 defense contractor General Dynamics Corp. a $327.8 million contract modification to continue development ...
Raytheon, a subsidiary of Arlington County-based Fortune 500 aerospace and defense contractor RTX, has been awarded a $646 million contract modification to continue producing the AN/SPY-6(V) family of ...
GAITHERSBURG, Md., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $30 million contract modification from the Biomedical Advanced Research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback